Athanase Innovation AB (OSTO:ATIN) EV-to-EBIT: 2.04 (As of Aug. 30, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:ATIN Athanase Innovation AB OSTO:ATIN
26 GF Score
Price kr20.40
View Full Analysis

What is Athanase Innovation AB EV-to-EBIT?

Athanase Innovation AB OSTO:ATIN -0.97% 26 EV-to-EBIT is 2.04 as of Aug. 30, 2026. GuruFocus rates OSTO:ATIN with a GF Score™ of 26/100.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Athanase Innovation AB's Enterprise Value is kr393.19 Mil. Athanase Innovation AB's EBIT for the trailing twelve months (TTM) ended in Dec. 2020 was kr192.77 Mil. Therefore, Athanase Innovation AB's EV-to-EBIT for today is 2.04.

The historical rank and industry rank for Athanase Innovation AB's EV-to-EBIT or its related term are showing as below:

OSTO:ATIN's EV-to-EBIT is not ranked *
in the Asset Management industry.
Industry Median: 9.38
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Athanase Innovation AB's Enterprise Value for the quarter that ended in Dec. 2020 was kr5,740.38 Mil. Athanase Innovation AB's EBIT for the trailing twelve months (TTM) ended in Dec. 2020 was kr192.77 Mil. Athanase Innovation AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2020 was 3.36%.


Athanase Innovation AB  (OSTO:ATIN) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Athanase Innovation AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2020 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2020 ) =EBIT / Enterprise Value (Q: Dec. 2020 )
=192.772/5740.376
=3.36 %

Athanase Innovation AB's Enterprise Value for the quarter that ended in Dec. 2020 was kr5,740.38 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Athanase Innovation AB's EBIT for the trailing twelve months (TTM) ended in Dec. 2020 was kr192.77 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Athanase Innovation AB EV-to-EBIT Related Terms


Athanase Innovation AB EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for Athanase Innovation AB's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Athanase Innovation AB EV-to-EBIT Chart

Athanase Innovation AB Annual Data
Trend Jun17 Jun18 Jun19
EV-to-EBIT
0.00 34.36 32.94

Athanase Innovation AB Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20
EV-to-EBIT Get a 7-Day Free Trial 0.00 32.94 0.00 32.42 0.00

OSTO:ATIN vs EVG, SMM, NHS: EV-to-EBIT Comparison

For the Asset Management subindustry, Athanase Innovation AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Athanase Innovation AB EV-to-EBIT vs Asset Management Industry

For the Asset Management industry and Financial Services sector, Athanase Innovation AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Athanase Innovation AB's EV-to-EBIT falls into.


OSTO:ATIN
26GF Score
Athanase Innovation AB OSTO:ATIN
EV-to-EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Athanase Innovation AB EV-to-EBIT Calculation

Athanase Innovation AB's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=393.187/192.772
=2.04

Athanase Innovation AB's current Enterprise Value is kr393.19 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Athanase Innovation AB's EBIT for the trailing twelve months (TTM) ended in Dec. 2020 was kr192.77 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-EBIT →
What does a EV-to-EBIT of 2.04 mean?
Athanase Innovation AB (OSTO:ATIN) has a EV-to-EBIT of 2.04 as of Aug. 30, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Athanase Innovation AB and its competitors.
Is Athanase Innovation AB's EV-to-EBIT too high?
Athanase Innovation AB's current EV-to-EBIT is 2.04. The Asset Management industry median EV-to-EBIT is 9.38. Athanase Innovation AB's value of 2.04 is 78.3% below this industry median. Overall, Athanase Innovation AB has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Athanase Innovation AB's EV-to-EBIT compare to EVG and SMM?
Athanase Innovation AB's EV-to-EBIT of 2.04 can be compared against companies in the Asset Management industry. The industry median EV-to-EBIT is 9.38. Athanase Innovation AB's value of 2.04 is 78.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for an Asset Management company?
The median EV-to-EBIT among Asset Management companies is 9.38, based on 501 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Athanase Innovation AB's current EV-to-EBIT of 2.04 is 78.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Athanase Innovation AB and its competitors. For the Asset Management industry, the median EV-to-EBIT is 9.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Athanase Innovation AB's current EV-to-EBIT is 2.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Athanase Innovation AB stock overvalued right now?
Athanase Innovation AB (OSTO:ATIN) has a current EV-to-EBIT of 2.04. The current EV-to-EBIT is 2.04 and 78.3% below the Asset Management industry median of 9.38. Athanase Innovation AB's overall GF Score™ is 26/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Athanase Innovation AB (OSTO:ATIN), the current EV-to-EBIT is 2.04 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Athanase Innovation AB Business Description

Address Birger Jarlsgatan 6, Sverige, Stockholm, SWE, 114 34
Athanase Innovation AB is an alternative investment firm with exposure to both private and public equity. It invests in innovative companies that benefit from trends such as robotics, digitalization, and automation. The principal revenue stream is initially management fees charged on the external fund capital and investment income of the underlying assets.
26GF Score

Get the complete analysis for OSTO:ATIN

EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr20.40
Price